Ambrx Biopharma Inc. ROE 2023-2023 | AMAM

Current and historical return on equity (ROE) values for Ambrx Biopharma Inc. (AMAM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-03-31 $-0.04B $0.18B -34.31%